These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 29515577)

  • 1. Immunization Strategies Producing a Humoral IgG Immune Response against Devil Facial Tumor Disease in the Majority of Tasmanian Devils Destined for Wild Release.
    Pye R; Patchett A; McLennan E; Thomson R; Carver S; Fox S; Pemberton D; Kreiss A; Baz Morelli A; Silva A; Pearse MJ; Corcoran LM; Belov K; Hogg CJ; Woods GM; Lyons AB
    Front Immunol; 2018; 9():259. PubMed ID: 29515577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The toll-like receptor ligands Hiltonol
    Patchett AL; Tovar C; Corcoran LM; Lyons AB; Woods GM
    Dev Comp Immunol; 2017 Nov; 76():352-360. PubMed ID: 28689773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for induction of humoral and cytotoxic immune responses against devil facial tumor disease cells in Tasmanian devils (Sarcophilus harrisii) immunized with killed cell preparations.
    Kreiss A; Brown GK; Tovar C; Lyons AB; Woods GM
    Vaccine; 2015 Jun; 33(26):3016-25. PubMed ID: 25708088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regression of devil facial tumour disease following immunotherapy in immunised Tasmanian devils.
    Tovar C; Pye RJ; Kreiss A; Cheng Y; Brown GK; Darby J; Malley RC; Siddle HV; Skjødt K; Kaufman J; Silva A; Baz Morelli A; Papenfuss AT; Corcoran LM; Murphy JM; Pearse MJ; Belov K; Lyons AB; Woods GM
    Sci Rep; 2017 Mar; 7():43827. PubMed ID: 28276463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demonstration of immune responses against devil facial tumour disease in wild Tasmanian devils.
    Pye R; Hamede R; Siddle HV; Caldwell A; Knowles GW; Swift K; Kreiss A; Jones ME; Lyons AB; Woods GM
    Biol Lett; 2016 Oct; 12(10):. PubMed ID: 28120799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitogen-activated Tasmanian devil blood mononuclear cells kill devil facial tumour disease cells.
    Brown GK; Tovar C; Cooray AA; Kreiss A; Darby J; Murphy JM; Corcoran LM; Bettiol SS; Lyons AB; Woods GM
    Immunol Cell Biol; 2016 Aug; 94(7):673-9. PubMed ID: 27089941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Devil Facial Tumor Disease.
    Pye RJ; Woods GM; Kreiss A
    Vet Pathol; 2016 Jul; 53(4):726-36. PubMed ID: 26657222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heat shock proteins expressed in the marsupial Tasmanian devil are potential antigenic candidates in a vaccine against devil facial tumour disease.
    Tovar C; Patchett AL; Kim V; Wilson R; Darby J; Lyons AB; Woods GM
    PLoS One; 2018; 13(4):e0196469. PubMed ID: 29702669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lessons learnt from the Tasmanian devil facial tumour regarding immune function in cancer.
    Peel E; Belov K
    Mamm Genome; 2018 Dec; 29(11-12):731-738. PubMed ID: 30225648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inducible IFN-γ Expression for MHC-I Upregulation in Devil Facial Tumor Cells.
    Ong CEB; Lyons AB; Woods GM; Flies AS
    Front Immunol; 2018; 9():3117. PubMed ID: 30692995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunology of a Transmissible Cancer Spreading among Tasmanian Devils.
    Woods GM; Howson LJ; Brown GK; Tovar C; Kreiss A; Corcoran LM; Lyons AB
    J Immunol; 2015 Jul; 195(1):23-9. PubMed ID: 26092814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural killer cell mediated cytotoxic responses in the Tasmanian devil.
    Brown GK; Kreiss A; Lyons AB; Woods GM
    PLoS One; 2011; 6(9):e24475. PubMed ID: 21957452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoglubolin dynamics and cancer prevalence in Tasmanian devils (Sarcophilus harrisii).
    Ujvari B; Hamede R; Peck S; Pemberton D; Jones M; Belov K; Madsen T
    Sci Rep; 2016 Apr; 6():25093. PubMed ID: 27126067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toll-like receptor signaling is functional in immune cells of the endangered Tasmanian devil.
    Patchett AL; Latham R; Brettingham-Moore KH; Tovar C; Lyons AB; Woods GM
    Dev Comp Immunol; 2015 Nov; 53(1):123-33. PubMed ID: 26182986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematologic and serum biochemical changes associated with Devil Facial Tumor Disease in Tasmanian Devils.
    Peck S; Corkrey R; Hamede R; Jones M; Canfield P
    Vet Clin Pathol; 2016 Sep; 45(3):417-29. PubMed ID: 27589840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversible epigenetic down-regulation of MHC molecules by devil facial tumour disease illustrates immune escape by a contagious cancer.
    Siddle HV; Kreiss A; Tovar C; Yuen CK; Cheng Y; Belov K; Swift K; Pearse AM; Hamede R; Jones ME; Skjødt K; Woods GM; Kaufman J
    Proc Natl Acad Sci U S A; 2013 Mar; 110(13):5103-8. PubMed ID: 23479617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complex associations between cancer progression and immune gene expression reveals early influence of transmissible cancer on Tasmanian devils.
    Raven N; Klaassen M; Madsen T; Jones M; Hamilton DG; Ruiz-Aravena M; Thomas F; Hamede RK; Ujvari B
    Front Immunol; 2024; 15():1286352. PubMed ID: 38515744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal plasticity of devil facial tumour cells during in vivo vaccine and immunotherapy trials.
    Patchett AL; Tovar C; Blackburn NB; Woods GM; Lyons AB
    Immunol Cell Biol; 2021 Aug; 99(7):711-723. PubMed ID: 33667023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MHC gene copy number variation in Tasmanian devils: implications for the spread of a contagious cancer.
    Siddle HV; Marzec J; Cheng Y; Jones M; Belov K
    Proc Biol Sci; 2010 Jul; 277(1690):2001-6. PubMed ID: 20219742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Immunomodulatory Small Molecule Imiquimod Induces Apoptosis in Devil Facial Tumour Cell Lines.
    Patchett AL; Darby JM; Tovar C; Lyons AB; Woods GM
    PLoS One; 2016; 11(12):e0168068. PubMed ID: 27936237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.